A new working group on sepsis and cancer has been launched at the initiative of the Jibraan Chaudhary Sepsis Research Foundation, in partnership with 8 other European organizations, with the aim of fully integrating sepsis into oncology care pathways.
Sepsis remains one of the most serious and underestimated complications affecting people with cancer. Patients undergoing chemotherapy—particularly those presenting with neutropenia—face an increased risk of infection, rapid clinical deterioration, and recurrent episodes of sepsis.
The sepsis and cancer working group aims to bring together multidisciplinary expertise to strengthen the prevention, early detection, and management of sepsis in cancer patients. It also seeks to bridge existing gaps in care pathways, research, and healthcare policies, ultimately improving outcomes for immunocompromised patients.
The working group will serve as a collaborative platform, bringing together clinicians, researchers, patient advocates, policymakers, and industry stakeholders to identify shared solutions at both national and European levels.
Partner organizations:
Latest news
On Thursday, September 24, 2026, the “Bridge the Gap” event, organized by Claire Richards and Roland Cahen, brought together 24 biologists, physicians, researchers, professors, and designers to discuss rapid Point-of-Care diagnosis of sepsis.
Maëlisse is a PhD student at MICALIS, INRAe. To gain a better understanding of the reality of sepsis in a hospital setting, she swapped her researcher’s lab coat for a clinical one for a week of shadowing in the Intensive Care Unit at Raymond-Poincaré Hospital in Garches.